Corilagin attenuates aerosol bleomycin-induced experimental lung injury

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 9762-9779

  Wang, Zheng ^a   Guo, Qiong Ya ^a   Zhang, Xiao Ju ^a   Li, Xiao ^a   Li, Wen Ting ^b   Ma, Xi Tao ^a   Ma, Li Jun ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

Author keywords

Apoptosis; Corilagin; NF B; Pulmonary fibrosis; TGF 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; CORILAGIN; CYTOKINE; HYDROXYPROLINE; I KAPPA B KINASE ALPHA; INTERLEUKIN 1ALPHA; MALONALDEHYDE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; GLUCOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSING ALVEOLITIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LUNG ALVEOLUS CELL; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; LUNG; PATHOLOGY; PULMONARY FIBROSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLEOMYCIN; CYTOKINES; GLUCOSIDES; LUNG; LUNG INJURY; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; OXIDATIVE STRESS; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901748144     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15069762     Document Type: Article

References (42)

1. Chen, X.; Zhang, X.; Li, X.; Wang, Z. Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2013, 41, 249-250.
2. Wang, Z.; Zhang, X.; Kang, Y.; Zeng, Y.; Liu, H.; Chen, X.; Ma, L. Stem cell therapy for idiopathic pulmonary fibrosis: How far are we from the bench to the bedside. J. Biomed. Sci. Eng. 2013, 6, 24-31.
3. Raghu, G.; Weycker, D.; Edelsberg, J.; Bradford, W.Z.; Oster, G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174, 810-816.
4. Raghu, G.; Collard, H.R.; Egan, J.J.; Martinez, F.J.; Behr, J.; Brown, K.K.; Colby, T.V.; Cordier, J.; Flaherty, K.R.; Lasky, J.A.; et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011, 183, 788-824.
5. Barbas-Filho, J.V.; Ferreira, M.A.; Sesso, A.; Kairalla, R.A.; Carvalho, C.R.; Capelozzi, V.L. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J. Clin. Pathol. 2001, 54, 132-138.
6. Plataki, M.; Koutsopoulos, A.V.; Darivianaki, K.; Delides, G.; Siafakas, N.M.; Bouros, D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005, 127, 266-274.
7. Moore, B.B.; Hogaboam, C.M. Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294, L152-L160.
8. Li, W.; Hu, Y.; Yuan, W.; Li, L.; Huang, W. Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin. Nan Fang Yi Ke Da Xue Xue Bao 2012, 32, 221-225.
9. El-Khouly, D.; El-Bakly, W.M.; Awad, A.S.; El-Mesallamy, H.O.; El-Demerdash, E. Thymoquinone blocks lung injury and fibrosis by attenuating bleomycin-induced oxidative stress and activation of nuclear factor Kappa-B in rats. Toxicology 2012, 302, 106-113.
10. Cavarra, E.; Carraro, F.; Fineschi, S.; Naldini, A.; Bartalesi, B.; Pucci, A.; Lungarella, G. Early response to bleomycin is characterized by different cytokine and cytokine receptor profiles in lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287, L1186-L1192.
11. Kalayarasan, S.; Sriram, N.; Sudhandiran, G. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta. Life Sci. 2008, 82, 1142-1153.
12. Degryse, A.L.; Tanjore, H.; Xu, X.C.; Polosukhin, V.V.; Jones, B.R.; Boomershine, C.S.; Ortiz, C.; Sherrill, T.P.; McMahon, F.B.; Gleaves, L.A.; et al. TGFbeta signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment. Am. J. Physiol. Lung Cell Mol. Physiol. 2011, 300, L887-L897.
13. Gharaee-Kermani, M.; Hu, B.; Phan, S.H.; Gyetko, M.R. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: Focus on TGFbeta signaling and the myofibroblast. Curr. Med. Chem. 2009, 16, 1400-1417.
14. Azuma, A.; Nukiwa, T.; Tsuboi, E.; Suga, M.; Abe, S.; Nakata, K.; Taguchi, Y.; Nagai, S.; Itoh, H.; Ohi, M.; et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2005, 171, 1040-1047.
15. Demedts, M.; Behr, J.; Buhl, R.; Costabel, U.; Dekhuijzen, R.; Jansen, HM.; MacNee, W.; Thomeer, M.; Wallaert, B.; Laurent, F.; et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005, 353, 2229-2242.
16. Hunninghake, G.W. Antioxidant therapy for idiopathic pulmonary fibrosis. N. Engl. J. Med. 2005, 353, 2285-2287.
17. Fujimoto, H.; D'Alessandro-Gabazza, C.N.; Palanki, M.S.; Erdman, P.E.; Takagi, T.; Gabazza, E.C.; Bruno, N.E.; Yano, Y.; Hayashi, T.; Tamaki, S.; et al. Inhibition of nuclear factor-kappaB in T cells suppresses lung fibrosis. Am. J. Respir. Crit. Care Med. 2007, 176, 1251-1260.
18. Selman, M.; King, T.E.; Pardo, A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001, 134, 136-151.
19. Cheng, J.T.; Lin, T.C.; Hsu, F.L. Antihypertensive effect of corilagin in the rat. Can. J. Physiol. Pharmacol. 1995, 73, 1425-1429.
20. Shiota, S.; Shimizu, M.; Sugiyama, J.; Morita, Y.; Mizushima, T.; Tsuchiya, T. Mechanisms of action of corilagin and tellimagrandin I that remarkably potentiate the activity of beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 2004, 48, 67-73.
21. Duan, W.; Yu, Y.; Zhang, L. Antiatherogenic effects of phyllanthus emblica associated with corilagin and its analogue. Yakugaku Zasshi 2005, 125, 587-591.
22. Hau, D.K.; Zhu, G.Y.; Leung, A.K.; Wong, R.S.; Cheng, G.Y.; Lai, P.B.; Tong, S.W.; Lau, F.Y.; Chan, K.W.; Wong, W.Y.; et al. In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma. Phytomedicine 2010, 18, 11-15.
23. Kinoshita, S.; Inoue, Y.; Nakama, S.; Ichiba, T.; Aniya, Y. Antioxidant and hepatoprotective actions of medicinal herb, Terminalia catappa L. from Okinawa Island and its tannin corilagin. Phytomedicine 2007, 14, 755-762.
24. Dong, X.R.; Luo, M.; Fan, L.; Zhang, T.; Liu, L.; Dong, J.H.; Wu, G. Corilagin inhibits the double strand break-triggered NF-kappaB pathway in irradiated microglial cells. Int. J. Mol. Med. 2010, 25, 531-536.
25. Guo, Y.J.; Zhao, L.; Li, X.F.; Mei, Y.W.; Zhang, S.L.; Tao, J.Y.; Zhou, Y.; Dong, J.H. Effect of Corilagin on anti-inflammation in HSV-1 encephalitis and HSV-1 infected microglias. Eur. J. Pharmacol. 2010, 635, 79-86.
26. Gambari, R.; Borgatti, M.; Lampronti, I.; Fabbri, E.; Brognara, E.; Bianchi, N.; Piccagli, L.; Yuen, M.C.; Kan, C.W.; Hau, D.K.; et al. Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells. Int. Immunopharmacol. 2012, 13, 308-315.
27. Huang, Y.F.; Chen, S.D.; Wang, Y.F.; Shi, H.X.; Jin, H.H.; Zhang, Y.; Zhao, L. Effects of Corilagin on expression of IL-13 in schistosomiasis liver fibrosis of mice liver tissue and therapeutic effect of anti-fibrosis. Chin. J. Interg. Trad. West Med. Liver Dis. 2011, 21, 156-158.
28. Sen, C.K.; Khanna, S.; Gordillo, G.; Bagchi, D.; Bagchi, M.; Roy, S. Oxygen, oxidants, and antioxidants in wound healing: An emerging paradigm. Ann. N. Y. Acad. Sci. 2002, 957, 239-249.
29. Serrano-Mollar, A.; Nacher, M.; Gay-Jordi, G.; Closa, D.; Xaubet, A.; Bulbena, O. Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 2007, 176, 1261-1268.
30. Mouratis, M.A.; Aidinis, V. Modeling pulmonary fibrosis with bleomycin. Curr. Opin. Pulm. Med. 2011, 17, 355-361.
31. Warshamana, G.S.; Corti, M.; Brody, A.R. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: Tnf-alpha induces TGF-beta(1). Exp. Mol. Pathol. 2001, 71, 13-33.
32. Zhang, K.; Gharaee-Kermani, M.; McGarry, B.; Remick, D.; Phan, S.H. TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. J. Immunol. 1997, 158, 954-959.
33. Mantawy, E.M.; Tadros, M.G.; Awad, A.S.; Hassan, D.A.; El-Demerdash, E. Insights antifibrotic mechanism of methyl palmitate: Impact on nuclear factor kappa B and proinflammatory cytokines. Toxicol. Appl. Pharmacol. 2012, 258, 134-144.
34. Kolb, M.; Margetts, P.J.; Anthony, D.C.; Pitossi, F.; Gauldie, J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Investig. 2001, 107, 1529-1536.
35. Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420-1428.
36. Cutroneo, K.R. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene. J. Cell. Biochem. 2006, 97, 933-939.
37. Bors, W.; Michel, C. Chemistry of the antioxidant effect of polyphenols. Ann. N. Y. Acad. Sci. 2002, 957, 57-69.
38. Zhao, L.; Zhang, S.L.; Tao, J.Y.; Pang, R.; Jin, F.; Guo, Y.J.; Dong, J.H.; Ye, P.; Zhao, H.Y.; Zheng, G.H. Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-Ogalloyl-3,6-(R)-hexahydroxydiphenoyl-D-glucose) in vitro. Int. Immunopharmacol. 2008, 8, 1059-1064.
39. Blenn, C.; Wyrsch, P.; Althaus, F.R. The ups and downs of tannins as inhibitors of poly(ADP-ribose)glycohydrolase. Molecules 2011, 16, 1854-1877.
40. Grzanna, R.; Lindmark, L.; Frondoza, C.G. Ginger-An herbal medicinal product with broad anti-inflammatory actions. J. Med. Food 2005, 8, 125-132.
41. Wang, Z.; Zhang, J.N.; Hu, X.F.; Chen, X.L.; Wang, X.R.; Zhao, T.T.; Peng, M.J.; Zou, P. Effects of pentoxifylline on Wnt/beta-catenin signaling in mice chronically exposed to cigarette smoke. Chin. Med. J. 2010, 123, 2688-2694.
42. Ashcroft, T.; Simpson, J.M.; Timbrell, V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 1988, 41, 467-470.